
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer
Wang, Yun, Herrstedt, Jørn, Havsteen, Hanne, DePoint Christensen, Rene, Mirza, Mansoor, Lund, Bente, Maenpaa, Johanna, Kristensen, GunnarVolume:
14
Année:
2014
Langue:
english
Journal:
BMC Cancer
DOI:
10.1186/1471-2407-14-937
Fichier:
PDF, 334 KB
english, 2014